Integra Lifesciences Holdings Corp (IART)
32.07
-0.73
(-2.23%)
USD |
NASDAQ |
Apr 15, 16:00
32.06
-0.01
(-0.03%)
After-Hours: 20:00
Integra Lifesciences Holdings Cash from Investing (TTM): -94.18M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -94.18M |
| September 30, 2023 | -91.77M |
| June 30, 2023 | -69.27M |
| March 31, 2023 | -58.22M |
| December 31, 2022 | -58.58M |
| September 30, 2022 | -31.24M |
| June 30, 2022 | -54.52M |
| March 31, 2022 | -57.94M |
| December 31, 2021 | -161.44M |
| September 30, 2021 | -169.88M |
| June 30, 2021 | -168.12M |
| March 31, 2021 | -164.15M |
| December 31, 2020 | -68.07M |
| September 30, 2020 | -52.76M |
| June 30, 2020 | -154.88M |
| March 31, 2020 | -168.35M |
| December 31, 2019 | -162.67M |
| September 30, 2019 | -167.39M |
| June 30, 2019 | -74.89M |
| March 31, 2019 | -56.21M |
| December 31, 2018 | -49.70M |
| September 30, 2018 | -1.008B |
| June 30, 2018 | -998.71M |
| March 31, 2018 | -1.037B |
| December 31, 2017 | -1.221B |
| Date | Value |
|---|---|
| September 30, 2017 | -258.91M |
| June 30, 2017 | -258.51M |
| March 31, 2017 | -229.04M |
| December 31, 2016 | -42.62M |
| September 30, 2016 | -59.30M |
| June 30, 2016 | -368.04M |
| March 31, 2016 | -373.11M |
| December 31, 2015 | -372.01M |
| September 30, 2015 | -433.04M |
| June 30, 2015 | -126.37M |
| March 31, 2015 | -122.61M |
| December 31, 2014 | -363.32M |
| September 30, 2014 | -274.59M |
| June 30, 2014 | -279.21M |
| March 31, 2014 | -283.54M |
| December 31, 2013 | -50.30M |
| September 30, 2013 | -69.94M |
| June 30, 2013 | -36.69M |
| March 31, 2013 | -28.53M |
| December 31, 2012 | -79.28M |
| September 30, 2012 | -65.08M |
| June 30, 2012 | -165.80M |
| March 31, 2012 | -248.29M |
| December 31, 2011 | -190.38M |
| September 30, 2011 | -194.05M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-169.88M
Minimum
Sep 2021
-31.24M
Maximum
Sep 2022
-106.75M
Average
-91.77M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
| Stryker Corp | -962.00M |
| OraSure Technologies Inc | 66.15M |
| Insulet Corp | -119.40M |
| PROCEPT BioRobotics Corp | -25.21M |
| Perspective Therapeutics Inc | 24.37M |